Donald Yoolee on Clubhouse

Bio

Follow my new account 🥺🙏🥂Donald Yoolee, M.D. I graduated with honors from Duke University and then started my medical education at the prestigious Baylor College of Medicine. 🇬🇧There he also attended undergraduate studies and graduated Manga with honors and got his bachelor's degree. The science of immunology. During his residency, Dr. Singh was intern at the Department of Oncology at Columbia University Medical Center in New York, NY. During his residency, he was able to provide excellent care and consultation, resulting in an overall improvement in our patient satisfaction index. He then completed a fellowship in Medical Oncology at his UCSF Medical Center in San Francisco, CA. Focusing on patient care, Dr. Singh re-evaluated several treatment management modalities according to cancer type, tailored to a patient's individual medical history and effectiveness of previous treatments. Since 1997, Dr. Singh has worked in the Department of Oncology at UCLA Medical Center in Los Angeles, California, one of the top 10 cancer specialty hospitals in the United States. His practice focuses on non-small cell lung cancer, and he is a pioneer in clinical research focused on anticancer drug treatments in various stages of clinical trials, working with researchers at the Medical Center. I work as
🎱 Currently in the Journal of American 🇺🇸 Medicine he has 8 publications and co-authored several others including Nature Medicine. He featured strong clinical results in the therapeutic efficacy of neucytoxan, one of his current most commonly used anticancer therapies for the treatment of many non-small cell lung cancers and myeloma. Listed as a major contributor to the publication. Dr. Singh currently holds certification in Internal Medicine, Hematology, and Medical Oncology from the American College of Physicians. Dr. Singh also worked on contracts on the Indian high seas and was awarded the 2013 Medical Community Leadership Development Award by the American Medical Association for his contributions to chemotherapy development in the field of oncology.